We are live on
!
Find out more
BF
BOK Financial Portfolio holdings
AUM
$7.25B
1-Year Est. Return
33.76%
This Fund
S&P 500
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+33.76%
3 Year Est. Return
+91.8%
5 Year Est. Return
+115.13%
10 Year Est. Return
–
AUM
$2.95B
AUM Growth
-$25.2M
(-0.85%)
Cap. Flow
+$13.2M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
928
New
85
Increased
401
Reduced
335
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$5.61M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$4.78M |
| 3 |
CME Group
CME
|
+$4.25M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.69M |
| 5 |
Intel
INTC
|
+$3.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$16.9M |
| 2 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$14M |
| 3 |
Skyworks Solutions
SWKS
|
+$7.92M |
| 4 |
Monster Beverage
MNST
|
+$5.4M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.02% |
| 2 | Energy | 12.65% |
| 3 | Healthcare | 10.91% |
| 4 | Industrials | 10.29% |
| 5 | Financials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$130B
| $19.6M | 0.66% |
293,828
+891
| +0.3% | +$58.7K |
|
27
Vanguard Real Estate ETF
VNQ
$37.2B
| $19M | 0.64% |
253,799
+30,096
| +13% | +$2.41M |
|
28
JPMorgan Chase
JPM
$937B
| $18.9M | 0.64% |
278,277
+10,224
| +4% | +$668K |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $18.8M | 0.64% |
162,436
-22,244
| -12% | -$2.54M |
|
30
3M
MMM
$84.9B
| $18.4M | 0.63% |
143,006
+1,740
| +1% | +$233K |
|
31
Chevron
CVX
$427B
| $18M | 0.61% |
186,174
-9,410
| -5% | -$988K |
|
32
PepsiCo
PEP
$185B
| $17.5M | 0.59% |
186,970
+12,781
| +7% | +$1.22M |
|
33
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $16.2M | 0.55% |
407,824
-3,028
| -0.7% | -$125K |
|
34
Alphabet (Google) Class C
GOOG
$4.18T
| $15.7M | 0.53% |
591,760
+57,297
| +11% | +$1.53M |
|
35
Walt Disney
DIS
$184B
| $15.5M | 0.53% |
135,737
-2,569
| -2% | -$282K |
|
36
AT&T
T
$183B
| $15.5M | 0.52% |
576,154
-28,049
| -5% | -$725K |
|
37
Starbucks
SBUX
$110B
| $14.7M | 0.5% |
274,724
-3,214
| -1% | -$163K |
|
38
iShares MSCI EAFE Growth ETF
EFG
$16.4B
| $14.5M | 0.49% |
207,976
-2,233
| -1% | -$162K |
|
39
SLB Ltd
SLB
$80.4B
| $14.4M | 0.49% |
167,518
-1,584
| -0.9% | -$143K |
|
40
iShares Core S&P Small-Cap ETF
IJR
$106B
| $14.4M | 0.49% |
244,226
-21,892
| -8% | -$1.29M |
|
41
iShares Russell Mid-Cap Growth ETF
IWP
$19B
| $14.3M | 0.49% |
296,074
+2,148
| +0.7% | +$106K |
|
|
42
Biogen
BIIB
$31.9B
| $14.2M | 0.48% |
35,230
+13,967
| +66% | +$5.61M |
|
43
Verizon
VZ
$214B
| $14.1M | 0.48% |
303,576
+1,744
| +0.6% | +$85.4K |
|
|
MRC
44
DELISTED
MRC Global
MRC
| $14M | 0.48% |
907,366
+140,337
| +18% | +$2.12M |
|
45
Altria Group
MO
$117B
| $14M | 0.47% |
285,461
-1,788
| -0.6% | -$90.6K |
|
46
Pfizer
PFE
$157B
| $13.8M | 0.47% |
434,939
+41,230
| +10% | +$1.34M |
|
47
Boeing
BA
$166B
| $13.8M | 0.47% |
99,578
+85
| +0.1% | +$12.4K |
|
|
48
Intel
INTC
$513B
| $13.8M | 0.47% |
453,925
+113,471
| +33% | +$3.67M |
|
49
Berkshire Hathaway Class B
BRK.B
$1.11T
| $13.8M | 0.47% |
101,238
+1,248
| +1% | +$178K |
|
50
Comcast
CMCSA
$86.7B
| $13.7M | 0.46% |
455,384
+44,412
| +11% | +$1.3M |
|
Similar funds
GI
GT
TB
SPC
OCM
SAM
CIMLRA
DE
BOK Financial's Q2 2015 Portfolio in Review
As of Q2 2015, BOK Financial held 928 positions worth $2.95B, down 0.85% from $2.97B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BOK Financial's Q2 2015 filing shows 85 new, 401 increased, 335 reduced and 70 closed positions. Its largest new stake was Spirit AeroSystems: 89,246 shares worth $4.92M. The largest sale was iShares S&P Mid-Cap 400 Growth ETF, an estimated $16.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Energy and Healthcare.
- BOK Financial's largest Q2 2015 buy was Spirit AeroSystems: 89,246 shares worth $4.92M.
- BOK Financial added most to Biogen in Q2 2015, an estimated $5.61M increase.
- BOK Financial's biggest Q2 2015 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $16.9M.
- BOK Financial fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $3.19M.
- BOK Financial's ten largest holdings make up 19% of its $2.95B portfolio in Q2 2015.
- BOK Financial opened 85 new positions and closed 70 in Q2 2015.
- BOK Financial's portfolio value fell 0.85% quarter-over-quarter to $2.95B.
Based on BOK Financial's 13F filing for Q2 2015, filed 13 Aug 2015.